Do we need to treat dialysis patients differently? Infliximab therapy in a patient with ulcerative colitis on hemodialysis: a case report
This case clearly illustrates the impact of comorbidities and the importance of a multidisciplinary approach in the management of elderly patients with inflammatory bowel disease. We demonstrated that infliximab therapy is effective and safe in the presence of concomitant severe inflammatory bowel disease and end-stage renal disease requiring hemodialysis.
Authors
- Akos Ilias
- Dorottya Angyal
- Lorant Gonczi
- Peter L. Lakatos
- Livia Lontai
- Fruzsina Balogh
Institutions
- Semmelweis University (HU)
- Military Hospital (PK)
- McGill University Health Centre (CA)
- Central Military Hospital (NL)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1186/s13256-026-05835-0
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00